Oral Health Group
News

Oral Drug Treatment Helps Protect Cancer Patients From Deadly Blood Clots

May 24, 2018
by University of Warwick, EurekAlert!


Oral drug treatment helps protect cancer patients from potentially deadly DVT and pulmonary embolism

  • Cancer patients are at high risk of developing blood clots
  • Deep vein thrombosis (DVT) and pulmonary embolism (PE) collectively known as venous thromboembolism (VTE), can cause death and disability
  • Tablet found to reduce recurrence of VTE

Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.

People with cancer have an increased risk of developing blood clots, with roughly one in five experiencing venous thromboembolism (VTE) – either deep vein thrombosis (DVT) or pulmonary embolism (PE). Blood clots in the deep veins of the leg may travel to the lungs causing a pulmonary embolism. These two conditions are referred to as VTE – a dangerous and potentially deadly medical condition of which there are 10 million cases worldwide.

To view the full story, please click here.